Henry Schein, Inc.
Every calculator, already run for HSIC
Open the full toolkit →You have the numbers on HSIC. Get the argument.
A written report on which of these readings actually decide the outcome for Henry Schein, Inc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
17 analysts covering HSICOwnership & short interest
About Henry Schein, Inc.
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restora…
HSIC — frequently asked
Is HSIC a buy right now?
Wall Street's consensus rating on Henry Schein, Inc. is Buy across 17 analysts, with a mean price target of $89.63 (+0% vs. the current $89.59). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is HSIC overvalued?
HSIC trades at 26.0x trailing earnings, against a DCF fair value of $113 per share. The current price implies 3% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is HSIC's next earnings date?
Henry Schein, Inc. is next scheduled to report earnings around Nov 3, 2026. A full HSIC research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
Compare Henry Schein, Inc. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For Henry Schein, Inc.
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full HSIC research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on Henry Schein, Inc., in minutes. 3 free reports included with every account — no credit card required.